Andaman7 Launches AI Supercharged Personal Health Record v5
Andaman7 Launches AI Supercharged Personal Health Record v5
New advanced AI Simplification, Summarization and Translation features empower patients and improve communication with healthcare providers and researchers.
Liège, Belgium, 2024-04-04: Andaman7, the free app transforming healthcare communications and bridging the gap between patients and researchers, has launched an update with advanced artificial intelligence (AI) capabilities. Version 5 of the app offers patients deeper insights into their own data, allowing researchers to leverage increased patient engagement for easier, faster, and better-quality studies and post market research.
Andaman7 v5 offers patients an enhanced understanding of their health record documents through three new AI tools:
- Simplification: Andaman7 AI streamlines complex medical information, converting medical jargon into text which is easier for patients to understand.
- Summarization: An AI-powered summarization extracts key insights allowing patients to quickly grasp the content of lengthy reports.
- Translation: A translation tool ensures health information is always accessible and understood, regardless of the document's original language or the reader's language.
All the new features work on multiple formats, including photos and scans of paper documents.
Patient Advocate and Andaman7 Founder Vincent Keunen said: “Andaman7 v5 is the next significant stride towards empowering patients to become actors in their own health by increasing not just access to data but understanding of medical records. It highlights how AI can be groundbreaking for patients, giving them more autonomy and improving communication with providers. Andaman7 v5 also has important implications for the industry. It allows greater insight into a patient’s medical history, offers new opportunities for real-world data (RWD) collection, and allows researchers to leverage the increased patient engagement which comes with increased understanding.”
Andaman7 is committed to continuous innovation and is already working on the next groundbreaking AI features. First, a hybrid Personal Health Record (PHR) summary combining structured data from the PHR with unstructured data extracted from documents using AI. Second, codification of unstructured data which, among other applications, will facilitate patient recruitment to clinical trials by identifying candidates based on inclusion and exclusion criteria. Third, data collection via AI-enabled scraping to allow patients around the world to scrape their patient portal and download data into their PHR. Watch this space for more on these exciting developments soon.
Andaman7's is making health data more accessible and actionable than ever before, in support of its patient empowerment mission. Find out more about Andaman7’s integrated platforms for all your data needs at https://www.andaman7.com/en/now-ai
For more information, contact b2b@andaman7.com
-ENDS-
About Vincent Keunen
Vincent Keunen is the founder and CEO of Andaman7. Previously, he developed numerous medical IT systems (a secure data exchange platform used by more than 90% of Belgian hospitals and family doctors, and a prevention EHR, managing today close to 1 million patients). Vincent was also the CIO of success story Lampiris and was awarded the CIO of the year prize for his work there. When Vincent was diagnosed with
Find out more about Vincent Keunen’s personal story at http://bit.ly/a7vkblogen.
About Andaman7
Andaman7 is a Belgian-American eHealth company and was created to significantly improve communication and efficiency in collaboration between healthcare actors: patients, doctors, and researchers. Andaman7’s unique "security by design and privacy by default" architecture does not store medical data in the cloud. Data is only stored on mobile devices and exchanged in a distributed peer to peer method. Andaman7‘s patient centric health intermediation platform is designed to help patients better manage their health data, enable outcome measurement for pharma and research, and support disease management for hospitals and doctors.
With particular strengths in RWE, QoL, and PRO studies, Andaman7 is in use by citizens of over 30 countries and available in 20 languages. Andaman7 is compliant with GDPR and HIPAA and is validated FDA 21 CFR part 11 and EU Annex 11 for clinical trials. For more detail, visit https://www.andaman7.com/